Teva Pharmaceutical Industries Ltd. (TEVA)
36.18
+0.13
(+0.36%)
USD |
NYSE |
Sep 01, 16:00
36.18
0.00 (0.00%)
After-Hours: 16:13
Teva Pharmaceutical Industries Debt to Equity Ratio : 2.176 for June 30, 2026
Debt to Equity Ratio Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| June 30, 2026 | 2.176 |
| March 31, 2026 | 2.055 |
| December 31, 2025 | 2.178 |
| September 30, 2025 | 2.355 |
| June 30, 2025 | 2.567 |
| March 31, 2025 | 2.705 |
| December 31, 2024 | 3.384 |
| September 30, 2024 | 3.178 |
| June 30, 2024 | 2.976 |
| March 31, 2024 | 2.740 |
| December 31, 2023 | 2.698 |
| September 30, 2023 | 2.929 |
| June 30, 2023 | 2.980 |
| March 31, 2023 | 2.676 |
| December 31, 2022 | 2.775 |
| September 30, 2022 | 2.466 |
| June 30, 2022 | 2.485 |
| March 31, 2022 | 2.495 |
| December 31, 2021 | 2.293 |
| September 30, 2021 | 2.309 |
| June 30, 2021 | 2.477 |
| March 31, 2021 | 2.543 |
| December 31, 2020 | 2.644 |
| September 30, 2020 | 2.72 |
| June 30, 2020 | 1.926 |
| Date | Value |
|---|---|
| March 31, 2020 | 1.960 |
| December 31, 2019 | 1.965 |
| September 30, 2019 | 1.991 |
| June 30, 2019 | 2.073 |
| March 31, 2019 | 1.980 |
| December 31, 2018 | 1.966 |
| September 30, 2018 | 1.663 |
| June 30, 2018 | 1.686 |
| March 31, 2018 | 1.652 |
| December 31, 2017 | 1.871 |
| September 30, 2017 | 1.210 |
| June 30, 2017 | 1.252 |
| March 31, 2017 | 1.018 |
| December 31, 2016 | 1.074 |
| September 30, 2016 | 1.049 |
| June 30, 2016 | 0.3621 |
| March 31, 2016 | 0.3351 |
| December 31, 2015 | 0.3348 |
| September 30, 2015 | 0.513 |
| June 30, 2015 | 0.5434 |
| March 31, 2015 | 0.4867 |
| December 31, 2014 | 0.443 |
| September 30, 2014 | 0.4436 |
| June 30, 2014 | 0.4606 |
| March 31, 2014 | 0.4968 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Debt to Equity Ratio Benchmarks
| Johnson & Johnson | 0.5771 |
| Eli Lilly & Co. | 1.621 |
| Bristol Myers Squibb Co. | 2.019 |
| RedHill Biopharma Ltd. | -- |
| MediWound Ltd. | 0.2676 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 39.86B |
| Total Liabilities (Quarterly) | 32.10B |
| Shareholders Equity (Quarterly) | 7.753B |
| Current Ratio | 0.8795 |
| Net Debt Paydown Yield | 0.03% |